Inspire Medical Systems, Inc. Operating Cash Flow
Inspire Medical Systems, Inc. (INSP) reported Operating Cash Flow of $36.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $23.23M, a 765.42% increase year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $12.85M.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $52.47M, a 24.16% decline year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $68.53M, a 31.07% increase year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $116.98M, a 10.19% decline from fiscal 2024.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $130.25M, a 428.32% increase from fiscal 2023.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $24.65M, a 113.10% increase from fiscal 2022.
- Inspire Medical Systems, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $11.57M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $36.08M 10-Q · filed 2026-08-03 | $88.55M derived: sum of 3 quarters · filed 2026-08-03 | $157.07M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $12.85M 10-Q · filed 2026-05-04 | $65.32M derived: sum of 2 quarters · filed 2026-05-04 | $133.84M derived: sum of 3 quarters · filed 2026-05-04 | $136.53M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $52.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $121.00M derived: sum of 2 quarters · filed 2026-02-13 | $123.68M derived: sum of 3 quarters · filed 2026-08-03 | $116.98M 10-K · filed 2026-02-13 |
| 2025-09-30 | $68.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $71.21M derived: sum of 2 quarters · filed 2026-08-03 | $64.51M 10-Q · filed 2025-11-03 | $133.69M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$4.02M 10-Q · filed 2026-08-03 | $65.16M derived: sum of 3 quarters · filed 2026-08-03 | $117.44M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$6.70M 10-Q · filed 2026-05-04 | $62.48M derived: sum of 2 quarters · filed 2026-05-04 | $114.76M derived: sum of 3 quarters · filed 2026-05-04 | $114.68M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $69.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $121.46M derived: sum of 2 quarters · filed 2026-02-13 | $121.39M derived: sum of 3 quarters · filed 2026-02-13 | $130.25M 10-K · filed 2026-02-13 |
| 2024-09-30 | $52.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $52.20M derived: sum of 2 quarters · filed 2025-11-03 | $61.06M 10-Q · filed 2025-11-03 | $78.33M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $8.78M 10-Q · filed 2025-08-04 | $26.05M derived: sum of 3 quarters · filed 2026-02-13 | $29.69M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $8.86M 10-Q · filed 2025-05-05 | $26.13M derived: sum of 2 quarters · filed 2026-02-13 | $29.77M derived: sum of 3 quarters · filed 2026-02-13 | $34.86M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $17.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.91M derived: sum of 2 quarters · filed 2026-02-13 | $26.00M derived: sum of 3 quarters · filed 2026-02-13 | $24.65M 10-K · filed 2026-02-13 |
| 2023-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $8.73M derived: sum of 2 quarters · filed 2024-11-04 | $7.39M 10-Q · filed 2024-11-04 | $26.66M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.75M 10-Q · filed 2024-08-06 | $23.02M derived: sum of 3 quarters · filed 2025-02-10 | $34.02M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$1.34M 10-Q · filed 2024-05-07 | $17.93M derived: sum of 2 quarters · filed 2025-02-10 | $28.93M derived: sum of 3 quarters · filed 2025-02-10 | $22.97M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $19.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $30.27M derived: sum of 2 quarters · filed 2025-02-10 | $24.32M derived: sum of 3 quarters · filed 2025-02-10 | $11.57M 10-K · filed 2025-02-10 |
| 2022-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.05M derived: sum of 2 quarters · filed 2023-11-07 | -$7.70M 10-Q · filed 2023-11-07 | -$6.97M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$5.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$18.70M 10-Q · filed 2023-08-01 | -$17.97M derived: sum of 3 quarters · filed 2024-02-09 | -$18.31M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | -$12.75M 10-Q · filed 2023-05-02 | -$12.01M derived: sum of 2 quarters · filed 2024-02-09 | -$12.35M derived: sum of 3 quarters · filed 2024-02-09 | -$22.47M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $734.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $396.00K derived: sum of 2 quarters · filed 2024-02-09 | -$9.72M derived: sum of 3 quarters · filed 2024-02-09 | -$20.12M 10-K · filed 2024-02-09 |
| 2021-09-30 | -$338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$10.45M derived: sum of 2 quarters · filed 2022-11-01 | -$20.85M 10-Q · filed 2022-11-01 | -$24.96M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | -$10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$20.52M 10-Q · filed 2022-08-02 | -$24.63M derived: sum of 3 quarters · filed 2023-02-10 | -$33.53M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | -$10.40M 10-Q · filed 2022-05-03 | -$14.51M derived: sum of 2 quarters · filed 2023-02-10 | -$23.42M derived: sum of 3 quarters · filed 2023-02-10 | -$48.67M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$13.02M derived: sum of 2 quarters · filed 2023-02-10 | -$38.27M derived: sum of 3 quarters · filed 2023-02-10 | -$53.05M 10-K · filed 2023-02-10 |
| 2020-09-30 | -$8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$34.16M derived: sum of 2 quarters · filed 2021-11-02 | -$48.94M 10-Q · filed 2021-11-02 | -$55.01M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$25.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$40.03M 10-Q · filed 2021-08-03 | -$46.10M derived: sum of 3 quarters · filed 2022-02-15 | -$49.05M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$14.78M 10-Q · filed 2021-05-04 | -$20.85M derived: sum of 2 quarters · filed 2022-02-15 | -$23.80M derived: sum of 3 quarters · filed 2022-02-15 | -$36.68M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$9.02M derived: sum of 2 quarters · filed 2022-02-15 | -$21.90M derived: sum of 3 quarters · filed 2022-02-15 | -$32.85M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$15.83M derived: sum of 2 quarters · filed 2020-11-02 | -$26.77M 10-Q · filed 2020-11-02 | -$29.36M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$12.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$23.83M 10-Q · filed 2020-08-04 | -$26.41M derived: sum of 3 quarters · filed 2021-02-24 | -$29.97M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$10.94M 10-Q · filed 2020-05-05 | -$13.53M derived: sum of 2 quarters · filed 2021-02-24 | -$17.08M derived: sum of 3 quarters · filed 2021-02-24 | -$23.22M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$6.14M derived: sum of 2 quarters · filed 2021-02-24 | -$12.28M derived: sum of 3 quarters · filed 2021-02-24 | -$18.69M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$9.69M derived: sum of 2 quarters · filed 2019-11-05 | -$16.11M 10-Q · filed 2019-11-05 | -$19.38M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$12.55M 10-Q · filed 2019-08-06 | -$15.83M derived: sum of 3 quarters · filed 2020-02-25 | -$18.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$6.42M 10-Q · filed 2019-05-07 | -$9.70M derived: sum of 2 quarters · filed 2020-02-25 | -$12.82M derived: sum of 3 quarters · filed 2020-02-25 | -$16.85M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$6.40M derived: sum of 2 quarters · filed 2020-02-25 | -$10.43M derived: sum of 3 quarters · filed 2020-02-25 | -$15.79M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$7.15M derived: sum of 2 quarters · filed 2018-11-06 | -$12.51M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$9.39M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$5.36M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$17.95M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |